Practical Bayesian Guidelines for Phase IIB Clinical Trials (Q4842831): Difference between revisions
From MaRDI portal
Added link to MaRDI item. |
Created claim: Wikidata QID (P12): Q52376624, #quickstatements; #temporary_batch_1711094041063 |
||
(4 intermediate revisions by 3 users not shown) | |||
Property / author | |||
Property / author: Richard M. Simon / rank | |||
Property / author | |||
Property / author: Richard M. Simon / rank | |||
Normal rank | |||
Property / MaRDI profile type | |||
Property / MaRDI profile type: MaRDI publication profile / rank | |||
Normal rank | |||
Property / full work available at URL | |||
Property / full work available at URL: https://doi.org/10.2307/2533377 / rank | |||
Normal rank | |||
Property / OpenAlex ID | |||
Property / OpenAlex ID: W2007648830 / rank | |||
Normal rank | |||
Property / Wikidata QID | |||
Property / Wikidata QID: Q52376624 / rank | |||
Normal rank |
Latest revision as of 15:17, 22 March 2024
scientific article; zbMATH DE number 786310
Language | Label | Description | Also known as |
---|---|---|---|
English | Practical Bayesian Guidelines for Phase IIB Clinical Trials |
scientific article; zbMATH DE number 786310 |
Statements
Practical Bayesian Guidelines for Phase IIB Clinical Trials (English)
0 references
3 October 1995
0 references
sample size
0 references
phase IIB clinical trial
0 references
informative prior
0 references
decision boundaries
0 references
operating characteristics
0 references